GetTopicDetailResponse(id=70f8939498e, topicName=達比加群酯, introduction=達比加群酯, content=null, image=null, comments=1, allHits=1073, url=https://h5.medsci.cn/topic?id=93949, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=11924, tagList=[TagDto(tagId=11924, tagName=達比加群酯)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=908830, encodeId=fdff908830ad, content=經年齡和體重調整的<a href='/topic/show?id=70f8939498e' target=_blank style='color:#2F92EE;'>#達比加群酯#</a>給藥方法適用于18歲以下的靜脈血栓栓塞患兒。達比加群酯的療效不遜色于標準護理，, objectTitle=Lancet haematol：達比加群酯有望替代靜脈血栓栓塞兒童患者的標準治療？, objectType=article, longId=204571, objectId=a2732045e132, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/p013gg1w.jpg, objectUrl=/article/show_article.do?id=a2732045e132, replyNumber=0, likeNumber=146, createdTime=2020-12-17, rootId=0, userName=Jessica, userId=3a345397082, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2732045e132, moduleTitle=Lancet haematol：達比加群酯有望替代靜脈血栓栓塞兒童患者的標準治療？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a2732045e132)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
